Cord Blood News Volume 7.12 | Apr 2 2015

    0
    115

    Cord Blood News 7.12 April 2, 2015

    Cord Blood News

         In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
    Cell Therapy News on Facebook   CBN on Twitter

     
    TOP STORY
    Novel Pathway for Hypoxia-Induced Proliferation and Migration in Human Mesenchymal Stem Cells: Involvement of HIF-1α, FASN, and mTORC1
    Investigators identified hypoxia-inducible lipid metabolic enzymes that can regulate umbilical cord blood (UCB)-derived human mesenchymal stem cell (hMSC) proliferation and migration and to demonstrated the signaling pathway that controls functional change in UCB-hMSCs. [Stem Cells] Abstract
    New Cord Banking Software Solution from STEMSOFT

     
    PUBLICATIONS (Ranked by impact factor of the journal)
    CD133 Allows Elaborated Discrimination and Quantification of Hematopoietic Progenitor Subsets in Human Hematopoietic Stem Cell Transplants
    To qualify the assessment of CD133 for routine quality control of adult hematopoietic stem cell (HSC) sources, researchers analyzed the developmental potentials of CD133+ and CD133low subpopulations in bone marrow and peripheral blood stem cells. Similar to umbilical cord blood, CD133 expression objectively discriminated functionally distinct subpopulations in adult HSC sources. [Br J Haematol] Abstract

    Computational Modeling of the Expansion of Human Cord Blood CD133+ Hematopoietic Stem/Progenitor Cells with Different Cytokine Combinations
    Scientists developed a computational model based on cellular signaling interactions that predict the influence of a cytokine on the survival, duplication and differentiation of the CD133+ hematopoietic stem and progenitor cell subset from human umbilical cord blood. [Bioinformatics] Abstract

    Paracrine Effects of Mesenchymal Stem Cells Induce Senescence and Differentiation of Glioblastoma Stem-Like Cells
    Scientists found that conditioned media from bone marrow and umbilical cord derived mesenchymal stem cells mediated cell cycle arrest of glioblastoma multiforme stem-like cells by downregulating cyclin D1. [Cell Transplant] Full Article

    Wnt3a Protein Reduces Growth Factor-Driven Expansion of Human Hematopoietic Stem and Progenitor Cells in Serum-Free Cultures
    Researchers demonstrated that exogenous Wnt3a protein suppresses rather than promotes the expansion of umbilical cord blood-derived CD34+ cells in serum free expansion cultures. [PLoS One] Full Article

    Hypothermia Augments Neuroprotective Activity of Mesenchymal Stem Cells for Neonatal Hypoxic-Ischemic Encephalopathy
    Scientists hypothesized that combined treatment with hypothermia and transplantation of human umbilical cord blood-derived mesenchymal stem cells would synergistically attenuate severe hypoxic-ischemic encephalopathy compared to stand-alone therapy. [PLoS One] Full Article

    Comparative Proteomic Analysis of Two Distinct Stem-Cell Populations from Human Amniotic Fluid
    Investigators characterized two distinct types of stem cells isolated from residual amniotic fluid material derived from prenatal diagnostic amniocentesis. [Mol Biosyst] Abstract

    Investigating the Effect of Hypoxic Culture on the Endothelial Differentiation of Human Amniotic Fluid-Derived Stem Cells
    Scientists investigated the ability of amniotic fluid-derived stem cells to differentiate down an endothelial lineage with the aim of producing an endothelial-like cell suitable for use in pre-vascularization. [J Anat] Abstract

    Differentiation of Human Umbilical Cord Mesenchymal Stem Cells into Germ-Like Cells in Mouse Seminiferous Tubules
    The authors’ previous study demonstrated that human umbilical cord mesenchymal stem cells (HUMSCs) were capable of differentiation into germ cells in vitro. To assess this potential in vivo, HUMSCs were microinjected into the lumen of seminiferous tubules of immunocompetent mice, which were treated with busulfan to destroy endogenous spermatogenesis. [Mol Med Rep] Abstract | Download Full Article

    Request a Sample: ReproTeSR™

     
    REVIEWS
    Novel Clinical Uses for Cord Blood Derived Mesenchymal Stromal Cells
    The field of stem cell biology has identified a number of stem cell sources including embryonic stem cells and adult stem cells that offer the potential to replace virtually all functional cells of the body. The authors discuss the potential of mesenchymal stromal cells from cord blood for regenerative medicine approaches. [Cytotherapy] Abstract

    Visit our reviews page to see a complete list of reviews in the cord blood research field.

     
    INDUSTRY NEWS
    Cordlife Partners with Sutter Neuroscience Institute to Treat Childhood Autism Using Cord Blood Stem Cells
    Cordlife India has partnered with Dr. Michael Chez, autism and epilepsy treatment pioneer from Sutter Neuroscience Institute to study the treatment of childhood autism using cord blood stem cells. [Cordlife India] Press Release

    BioLineRx Reports Successful Top-Line Safety and Efficacy Results for Novel Stem Cell Mobilization Treatment
    BioLineRx Ltd. announced successful top-line results from the Phase I safety and efficacy study of its lead clinical candidate, BL-8040, as a novel approach for mobilization and collection of bone-marrow stem cells from the peripheral blood circulation. [BioLineRx Ltd.] Press Release

    From our sponsor: Free mouse hematopoietic progenitors wallchart. Request your copy.

     
    POLICY NEWS
    National Institutes of Health (United States)

    Food and Drug Administration (United States)

    Center for Biologics Evaluation and Research (United States)

    European Medicines Agency (European Union)

    Medicines and Healthcare Products Regulatory Agency (United Kingdom)

    Therapeutic Goods Administration (Australia)

     
    EVENTS
    NEW Frontiers in Stem Cells and Regeneration
    September 27-October 3, 2015
    Woods Hole, United States

    Visit our events page to see a complete list of events in the cord blood community.

     
    JOB OPPORTUNITIES
    NEW Postdoctoral Research Fellow – Stem Cell/Hematopoiesis Research (BloodCenter of Wisconsin)

    Principal Scientist – Hematopoietic Products (STEMCELL Technologies Inc.)

    Research Associate – Cell Separation (STEMCELL Technologies Inc.)

    Postdoctoral Research Fellow – Hematopoietic Stem Cell Biology (University of Leuven)

    Research Associate – Hematopoietic and Leukemic Stem Cells (Shanghai Jiao-Tong University School of Medicine)

    Research Scientist – Cell Signaling in Normal and Leukemic Hematopoietic Stem and Progenitor Cells (Indiana University)

    Manufacturing Manager – Cell Therapy (Opexa Therapeutics)

    Postdoctoral Fellows – Leukemia Research and Stem Cell Biology (Josep Carreras Leukemia Research Institute)

    PhD Studentships – Expansion of Umbilical Cord Blood Stem Cells (University College London)

    Cord Tissue Processing Technician (Cord Blood Registry)


    Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

     

    Have we missed an important article or publication in Cord Blood News? Click here to submit!

    Comments or suggestions? Submit your feedback here

    Learn more about Cord Blood News: Archives | Events | Contact Us